418 related articles for article (PubMed ID: 1875046)
1. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
Demidem A; Taylor JR; Grammer SF; Streilein JW
J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
[TBL] [Abstract][Full Text] [Related]
3. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
Prens EP; Benne K; van Joost T; Benner R
J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
[TBL] [Abstract][Full Text] [Related]
4. Effects of chloroquine on antigen-presenting functions of epidermal cells from normal and psoriatic skin.
Demidem A; Taylor JR; Grammer SF; Streilein JW
J Invest Dermatol; 1992 Feb; 98(2):181-6. PubMed ID: 1732381
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis.
Demidem A; Taylor JR; Grammer SF; Streilein JW
J Invest Dermatol; 1991 Apr; 96(4):401-7. PubMed ID: 1826121
[TBL] [Abstract][Full Text] [Related]
6. Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes.
Streilein JW; Grammer SF; Yoshikawa T; Demidem A; Vermeer M
Immunol Rev; 1990 Oct; 117():159-83. PubMed ID: 2258190
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
8. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
[TBL] [Abstract][Full Text] [Related]
9. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
Dai R; Grammer SF; Streilein JW
J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Langerhans cell function via blood borne factor(s).
Xie Y; Streilein JW
J Dermatol Sci; 1996 Sep; 12(3):263-74. PubMed ID: 8884532
[TBL] [Abstract][Full Text] [Related]
11. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
12. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.
Streilein JW; Grammer SF
J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
14. Skin-infiltrating lymphocytes in normal and disordered skin: activation signals and functional roles in psoriasis and mycosis fungoides-type cutaneous T cell lymphoma.
Cooper KD
J Dermatol; 1992 Nov; 19(11):731-7. PubMed ID: 1293160
[TBL] [Abstract][Full Text] [Related]
15. BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells.
Borek I; Köffel R; Feichtinger J; Spies M; Glitzner-Zeis E; Hochgerner M; Sconocchia T; Krump C; Tam-Amersdorfer C; Passegger C; Benezeder T; Tittes J; Redl A; Painsi C; Thallinger GG; Wolf P; Stary G; Sibilia M; Strobl H
J Allergy Clin Immunol; 2020 Apr; 145(4):1194-1207.e11. PubMed ID: 31870764
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
18. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness.
Cruz PD; Bergstresser PR
Dermatol Clin; 1990 Oct; 8(4):633-47. PubMed ID: 1979019
[TBL] [Abstract][Full Text] [Related]
19. Influence of microenvironmental factors on human Langerhans cell function in vitro.
Demidem A; Taylor JR; Grammer SF; Streilein JW
Reg Immunol; 1990-1991; 3(6):297-304. PubMed ID: 2151920
[TBL] [Abstract][Full Text] [Related]
20. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
Lisby S; Baadsgaard O; Cooper KD; Hansen ER; Mehregan D; Thomsen K; Allen E; Lange Vejlsgaard G
Scand J Immunol; 1990 Aug; 32(2):111-9. PubMed ID: 1697095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
